Difficulty: Medium
Average Score: 64%
Practice
Pathogenesis of hyperkalemic (Type IV) renal tubular acidosis is due to
Correct answer
B
Rationale
The correct answer is B) inhibiting ammonia genesis. In hyperkalemic (Type IV) renal tubular acidosis, there is impaired ammoniagenesis in the proximal tubule leading to decreased NH4+ excretion. This results in decreased buffering capacity in the urine, leading to hyperkalemia and metabolic acidosis.
Option A) hyperaldosteronism is incorrect because hyperkalemic (Type IV) RTA is not due to excess aldosterone activity. Option C) pseudohyperaldosteronism is incorrect as well because it does not play a direct role in the pathogenesis of hyperkalemic RTA. Option D) massive bicarbonate wasting is incorrect as this would be more characteristic of a different type of RTA (Type II).
Understanding the pathogenesis of hyperkalemic (Type IV) renal tubular acidosis is crucial for nurses and healthcare professionals caring for pediatric patients with renal disorders. By grasping the mechanisms involved, healthcare providers can better manage electrolyte imbalances and acid-base disturbances in these patients. This knowledge is especially important when administering medications or fluids that can impact renal function in pediatric patients.
Option A) hyperaldosteronism is incorrect because hyperkalemic (Type IV) RTA is not due to excess aldosterone activity. Option C) pseudohyperaldosteronism is incorrect as well because it does not play a direct role in the pathogenesis of hyperkalemic RTA. Option D) massive bicarbonate wasting is incorrect as this would be more characteristic of a different type of RTA (Type II).
Understanding the pathogenesis of hyperkalemic (Type IV) renal tubular acidosis is crucial for nurses and healthcare professionals caring for pediatric patients with renal disorders. By grasping the mechanisms involved, healthcare providers can better manage electrolyte imbalances and acid-base disturbances in these patients. This knowledge is especially important when administering medications or fluids that can impact renal function in pediatric patients.